Dave Mawhinney

Angel investor in Pittsburgh

Invests in AI

Dave Mawhinney's investor profile lists AI alongside Healthcare & Biotech, Biotech & Pharma and SaaS & Enterprise, at seed. The record holds 5 deals, among them Acrinta, Fiduciary and Advisory.

Email Investor

Email Investor

Credits to line up before a seed round

Dave Mawhinney backs companies at seed. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • Acrinta
  • Fiduciary
  • Advisory
  • Ben Franklin Technology Partners
  • PNC

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, Biotech & Pharma, SaaS & Enterprise, Consumer & Retail, Climate & Energy and 10 more
Rounds
Seed
Profile
Angel investor
Deals on record
5
Based in
Pittsburgh, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Dave Mawhinney invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Dave Mawhinney's investor profile, together with Healthcare & Biotech, Biotech & Pharma and SaaS & Enterprise. The stages on record are seed.
Which companies has Dave Mawhinney backed?
The record lists 5 deals, including Acrinta, Fiduciary, Advisory, Ben Franklin Technology Partners and PNC. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Dave Mawhinney?
For a company raising a seed round, AI Perks lists credits such as AWS (up to $300,000), Google Cloud (up to $350,000), Modal (up to $50,000) and Claude (up to $20,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor